Description

(9S)-9-Deoxo-9-[[(2-Methylphenyl)Sulfonyl]Amino]Erythromycin CAS NO 61066-22-6 is a chemically modified derivative of the macrolide antibiotic erythromycin, designed to enhance specific pharmacological properties. This compound is of significant interest for its potential to overcome bacterial resistance mechanisms and improve pharmacokinetic profiles. It is primarily utilized by pharmaceutical R&D teams and manufacturers engaged in the development of advanced antibacterial agents and novel therapeutic formulations.

Application

• Pharmaceutical Intermediate: Serves as a key synthetic precursor in the research and production of next-generation macrolide antibiotics.
• Antibacterial Agent Development: Used in preclinical studies to investigate structure-activity relationships (SAR) and efficacy against resistant bacterial strains.
• Biochemical Research: Employed as a tool compound in microbiological and pharmacological research to study bacterial protein synthesis inhibition.
• Veterinary Medicine: Potential application in developing advanced antibacterial treatments for veterinary use.
• Reference Standard: Serves as a high-purity analytical standard for quality control and regulatory compliance in pharmaceutical manufacturing.

Basic Information

Product Name	(9S)-9-Deoxo-9-[[(2-Methylphenyl)Sulfonyl]Amino]Erythromycin
CAS No.	61066-22-6
Molecular Formula	C38H66N2O12S
Molecular Weight	774.99 g/mol
Synonyms	9-Deoxo-9-[(o-tolylsulfonyl)amino]erythromycin; 9(S)-9-Deoxo-9-[(2-methylphenyl)sulfonylamino]erythromycin; Erythromycin 9-(2-methylbenzenesulfonamide), 9-deoxo-; N-[(9S)-9-Deoxo-9-erythromyciny1]-2-methylbenzenesulfonamide; (9S)-9-Deoxo-9-[(2-methylphenyl)sulfonylamino]erythromycin; Antibiotic 61066-22-6
EINECS	Contact for details

Quality Control

Our (9S)-9-Deoxo-9-[[(2-Methylphenyl)Sulfonyl]Amino]Erythromycin is manufactured under strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity, identity confirmation by IR and NMR spectroscopy, and stringent control of related substances and residual solvents. Certificates of Analysis (COA) documenting compliance with in-house pharmaceutical-grade specifications are provided with every shipment to ensure traceability and quality assurance for your critical R&D and production needs.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). Due to its hygroscopic (moisture-sensitive) nature, the container must be kept tightly sealed in a dry environment to prevent degradation. For long-term storage, consider desiccants or inert atmosphere.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 1.0%
Residual Solvents (GC)	Complies with ICH guidelines

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.